Filter Results:
(185)
Show Results For
- All HBS Web
(185)
- People (1)
- News (53)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (54)
Show Results For
- All HBS Web
(185)
- People (1)
- News (53)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (54)
Page 1 of 185
Results →
- November 2018
- Case
David Hysong and SHEPHERD Therapeutics
By: Ananth Raman, John Masko and Aldo Sesia
In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his... View Details
- March 2024
- Supplement
Miracle Therapeutics (B)
By: Satish Tadikonda, William Marks and Wendi Yajnik
Supplements the (A) case. Following on the negotiations detailed in the Miracle Therapeutics (A) case, Beth Sharp and Jennifer Brilliant from Miracle Therapeutics face new challenges with their company's funding and intellectual property (IP) after several missteps.... View Details
Keywords: Business Startups; Financing and Loans; Intellectual Property; Problems and Challenges; Business or Company Management
Tadikonda, Satish, William Marks, and Wendi Yajnik. "Miracle Therapeutics (B)." Harvard Business School Supplement 824-044, March 2024.
- September 2019
- Case
Nimbus Therapeutics
By: Peter Barrett, Karim Lakhani and Julia Kelley
This case focuses on Nimbus Therapeutics, a biotechnology startup based in Cambridge, Massachusetts, as its leadership team tries to determine the company’s long-term strategy. The startup’s founders structured Nimbus as a limited liability company, which has given it... View Details
Barrett, Peter, Karim Lakhani, and Julia Kelley. "Nimbus Therapeutics." Harvard Business School Case 620-016, September 2019.
- August 2024
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
- August 2023 (Revised August 2023)
- Case
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details
Keywords: Business Startups; Entrepreneurship; Mission and Purpose; Health Industry; Technology Industry
Tadikonda, Satish, Olivia Reszczynski, and William Marks. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 824-023, August 2023. (Revised August 2023.)
- September 2014
- Case
Pfizer's Centers for Therapeutic Innovation (CTI)
By: Gary Pisano, James Weber and Kait Szydlowski
In 2010, Pfizer established four small research units in New York, Boston, San Francisco, and San Diego located close to several premier Academic Medical Centers (AMCs), or hospitals with adjoining medical schools. The goal of these units was to redesign collaboration... View Details
Keywords: Drug Development; Academic Collaboration; Research And Development; Innovation; Translational Research; Management; Operations; Problems and Challenges; Research; Science; Information Technology; Strategy; Biotechnology Industry; Pharmaceutical Industry; North and Central America; Europe; Asia
Pisano, Gary, James Weber, and Kait Szydlowski. "Pfizer's Centers for Therapeutic Innovation (CTI)." Harvard Business School Case 615-024, September 2014.
- November 2016
- Case
Anthony Starks at InSiL Therapeutics (A)
By: Gary Pisano and Vicki Sato
When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a few months in, Wayne and Starks begin to clash over crucial forward-looking decisions about the... View Details
Keywords: Biotech; Silicon; Managing Innovation; Management Challenges; Managing People; Managing Organization; R&D; R&D Project Management; Platform; Venture Capital; Drug Discovery; management; Biotechnology Industry; California
Pisano, Gary, and Vicki Sato. "Anthony Starks at InSiL Therapeutics (A)." Harvard Business School Case 617-029, November 2016.
- 23 Apr 2019
- Video
X-Cor Therapeutics Final Pitch New Venture Competition 2019 Alumni Track
- 13 Feb 2023
- News
Alumnus Gift Will Nurture Basic, Therapeutic Science
Swiss biotech executive, entrepreneur, and philanthropist Ernesto Bertarelli (MBA 1993) has pledged $75 million to advance basic scientific discovery, therapeutic science, and a culture of entrepreneurship at Harvard Medical School. The... View Details
- November 2016 (Revised December 2016)
- Supplement
Anthony Starks at InSiL Therapeutics (B)
By: Vicki Sato and Gary Pisano
This case accompanies the (A) case from Anthony Starks's perspective. View Details
Keywords: Biotech; Management Challenges; R&D; R&D Project Management; Management; Biotechnology Industry; California
Sato, Vicki, and Gary Pisano. "Anthony Starks at InSiL Therapeutics (B)." Harvard Business School Supplement 617-030, November 2016. (Revised December 2016.)
- 15 Jul 2020
- Video
The HBS Health Minute: Translating Science into Therapeutics
- 25 Mar 2016
- Video
Duke Rohlen, Spirox & Advanced Cardiac Therapeutics
- 31 Jan 2020
- Video
Blavatnik Fellow Jayon Wang Propelling X-COR Therapeutics Forward
- August 2023
- Case
Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company
By: Satish Tadikonda and Brad Prosek
Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
Tadikonda, Satish, and Brad Prosek. "Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company." Harvard Business School Case 824-032, August 2023.
- 03 Nov 2017
- HBS Seminar
Jason Gardner, PhD, Magenta Therapeutics (CEO, President and Cofounder)
- 12 PM – 1 PM EDT, 26 May 2021
- Virtual Programming
Perspectives in Health: On Biotechnology Capital Strategy and the Future of Therapeutics
HBS Professor Amitabh Chandra will lead a discussion with Katrine Bosley to discuss the explosion of new ideas, capital in Life Sciences and the implications this has on the next generation of therapeutics. This hour-long discussion will include a Q&A for participants... View Details
- May 2021
- Case
The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease
By: Amitabh Chandra, Spencer Lee-Rey and Caroline Marra
This case explores incentives for rare disease drug development by chronicling the role of the Spinal Muscular Atrophy (SMA) Foundation in forming strategic partnerships with the scientific research community and pharmaceutical developers to transform the trajectory... View Details
Keywords: Innovation and Invention; Strategy; Business or Company Management; Society; Health; Public Administration Industry; Health Industry; United States
Chandra, Amitabh, Spencer Lee-Rey, and Caroline Marra. "The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease." Harvard Business School Case 621-112, May 2021.
- 1983
- Article
Level of Functioning and Length of Time in Treatment Variables Influencing Patient's Therapeutic Experience in Group Psychotherapy
By: Timothy Butler and Adelaide Fhuriman
Butler, Timothy, and Adelaide Fhuriman. "Level of Functioning and Length of Time in Treatment Variables Influencing Patient's Therapeutic Experience in Group Psychotherapy." International Journal of Group Psychotherapy 33, no. 4 (1983).
- September 2012
- Supplement
Intraoperative Radiotherapy for Breast Cancer (B)
By: Willy Shih
The intraoperative radiotherapy (IORT) business at Carl Zeiss Meditec had struggled with growth since the time of the (A) case. Though the unit had grown revenues in excess of 50% and had exceeded its EBIT target, it faced several key strategic choices. Should it... View Details
Keywords: Radiotherapy; Breast Cancer; Brachytherapy; Therapeutic Radiation; Oncology; Oncology Treatment Systems; Elekta AB; Varian Medical Systems; Xoft; Electronic Brachytherapy; Intraoperative Radiotherapy; Disruptive Innovation; Health Care and Treatment; Entrepreneurship; Technological Innovation; Growth and Development Strategy; Health Industry; Germany
Shih, Willy. "Intraoperative Radiotherapy for Breast Cancer (B)." Harvard Business School Supplement 613-040, September 2012.
- February 2019 (Revised May 2019)
- Case
Hot Chicken Takeover
By: William R. Kerr, Manjari Raman and Olivia Hull
By December 2018, entrepreneur Joe DeLoss’s fried chicken company, Hot Chicken Takeover, has opened three restaurants in Columbus, Ohio, using an unconventional employment model that helps people with criminal records get back on their feet. DeLoss is proud of the... View Details
Keywords: Fair Chance Employment; Fair Chance Hiring; Open Hiring; Inclusive Hiring; Criminal Record; Homelessness; Therapeutic Employment; Corporate Culture; Managing The Future Of Work; Food; Entrepreneurship; Social Entrepreneurship; Values and Beliefs; Fairness; Human Resources; Compensation and Benefits; Recruitment; Employees; Retention; Selection and Staffing; Innovation Strategy; Job Offer; Job Interviews; Human Capital; Leadership; Growth Management; Corporate Social Responsibility and Impact; Mission and Purpose; Social Enterprise; Social Issues; Poverty; Welfare; Food and Beverage Industry; Ohio; United States
Kerr, William R., Manjari Raman, and Olivia Hull. "Hot Chicken Takeover." Harvard Business School Case 819-078, February 2019. (Revised May 2019.)